7th Annual International Conference for Rare Diseases and Orphan Drugs Regulatory Aspects of Orphan Drugs – FDA Perspective Debra Lewis, OD, MBA Deputy Director - Lewis Drug - Document - PDFSEARCH.IO

First Page	Meta Content
	7th Annual International Conference for Rare Diseases and Orphan Drugs Regulatory Aspects of Orphan Drugs – FDA Perspective Debra Lewis, OD, MBA Deputy Director Add to Reading List Document Date: 2012-07-24 07:43:02 Open Document File Size: 556,06 KB Share Result on Facebook Country United States / / MedicalCondition Rare Diseases / Diseases / Hematologic-immunologic Neurologic Infectious / different rare disease / / Organization U.S. Food and Drug Administration / MBA Deputy Director Office / FDA / / Technology Transplantation / / SocialTag Food and Drug Administration Pharmaceuticals policy Drug discovery Orphan drug Pharmacology Center for Drug Evaluation and Research Rare disease Orphan Drug Act Pharmaceutical sciences Clinical research

7th Annual International Conference for Rare Diseases and Orphan Drugs Regulatory Aspects of Orphan Drugs – FDA Perspective Debra Lewis, OD, MBA Deputy DirectorAdd to Reading List